He serves as Consultant QP/RP/RPi, bringing extensive UK and EU regulatory expertise that is critical to delivering robust and compliant pharmacovigilance (PV) systems. With deep knowledge of MHRA requirements, EU GDP/GMP standards, and post-marketing safety regulations, he ensures that PV operations are aligned with global compliance expectations.
Ensures regulatory-compliant pharmacovigilance frameworks and quality systems aligned with UK and EU requirements.
Supports inspection readiness and audit compliance through robust processes and governance.
Provides QP, RP, and RPi oversight for both clinical and commercial products, covering small and large molecules.
Guides risk management systems and establishes effective safety governance structures.
Enables seamless coordination between pharmacovigilance, quality, and regulatory functions.
Delivers cost-effective, scalable, and inspection-ready PV systems, ensuring full compliance and strengthening client confidence across UK and EU markets.